PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Panic Disorder

Psychiatric Times. Vol. 25 No. 2
Pages: 1  2  
Previous
 

Panic-Focused Psychodynamic Psychotherapy

By Fredric N. Busch, MD and Barbara L. Milrod, MD | February 1, 2008
Dr Busch is clinical associate professor of psychiatry and Dr Milrod is professor of psychiatry at Weill Medical College of Cornell University in New York City. They report no conflicts of interest concerning the subject matter of this article.

Our group recently completed a landmark study in which we demonstrated efficacy of PFPP for panic disorder with and without agoraphobia.18 This was a randomized controlled trial comparing PFPP to a less-active psychotherapy, ART.19 Inclusion criteria were a diagnosis of primary DSM-IV panic disorder with or without agoraphobia (ADIS-IV-L), with at least 1 panic attack per week. Patients entering the study agreed to stop all nonstudy psychotherapy and to hold their medication constant if they were taking medication (15% of the sample). Patients with comorbid severe agoraphobia, major depression, and DSM-IV personality disorders were included. Exclusion criteria were psychosis, bipolar disorder, and substance abuse (6-months remission necessary).

The Panic Disorder Severity Scale (PDSS) was the primary outcome measure.35 Response was defined as a 40% reduction from baseline on the PDSS.1 Patients were assessed with the Sheehan Disability Scale (SDS),36 the Hamilton Rating Scale for Anxiety (HAM-A),37 and the Hamilton Rating Scale for Depression (HAM-D).38 Both therapies were of 12 weeks' duration, with twice-weekly (24 session) interventions. ART included a cognitive explanation about panic disorder, progressive muscle relaxation, cue-controlled relaxation, twice-daily homework, and an exposure protocol.

Psychotherapy sessions were videotaped for adherence monitoring. Both groups demonstrated high levels of adherence to the manualized treatments based on an assessment of 3 videotapes of each therapy using condition-specific adherence measures: the PFPP Adherence Rating Scale (available from the authors) and the ART Adherence Scale.39

No significant demographic or clinical differences were found between the 2 treatment groups at baseline besides sex—more men were in the ART group: 47% versus 15%; 2-tailed Fisher's exact P < .05 (Table 1). There were no baseline differences between randomized groups in severity of panic disorder, PDSS score, or baseline severity ratings. PFPP had a significantly higher response rate than ART: 73% versus 39%; P = .016 (Table 2); and significantly greater improvement in symptoms of panic disorder: PDSS, P = .002 (Figure 3) and psychosocial function: SDS, P = .014. The 2 treatments did not differ significantly in changes on the HAM-D (P = .07) or in nonpanic anxiety (HAM-A, P = .58).

Only 2 patients in the PFPP group dropped out (7%), an unusually low attrition rate for a randomized controlled trial of panic disorder in the United States, compared with 8 dropouts in the ART group (34%). Patients had good response to treatment despite the inclusion of severe agoraphobia and comorbid depression, making this sample relatively more generalizable than subjects in some other panic disorder outcome studies.1,2,7,40,41 PFPP performed comparably to clinical trials of cognitive-behavioral therapy (CBT) and medication, but these treatments were not directly compared with one another. Currently, a 2-site study (Cornell, New York and University of Pennsylvania, Philadelphia) is under way comparing PFPP with CBT and ART.

Preliminary moderator analyses of the efficacy study showed that patients with primary DSM-IV panic disorder with comorbid SCID-II-diagnosed Axis II cluster C disorders responded better to PFPP than patients without this comorbidity.42 Because panic patients with cluster C comorbidity have not always responded well to CBT,43 PFPP may be of particular value for this population.

Although the results of the PFPP studies are promising, further studies are needed to determine which treatment interventions are most appropriate for any given patient with panic disorder.

Case Vignette

Mr B had onset of severe panic disorder 2 days after his 39th birthday and presented with a score of 12 on the PDSS. In the first phase of treatment, the therapist explored the circumstances surrounding panic onset. Although Mr B acknowledged that he had been "stressed," he was puzzled about the source of the panic attacks. He focused initially on problems at work: he was not comfortable with the pressure at work since being promoted to leader of his division. As therapy progressed, he started to realize that he had been having some of the symptoms of his subsequent panic attacks for several weeks before their onset when having to reprimand or fire employees. Specifically, he felt tremors in his arms and a sense of loss of control.

Mr B described a difficult background. His father was a temperamental man who was especially intolerant of his son's early reading and writing difficulties. He described his mother as self-absorbed, often neglecting him. On 3 occasions, his parents sent him away from home, once to relatives and twice to boarding schools, for reasons he did not understand at the time. As a child, he assumed he was sent away because he was "bad," or he was being punished for losing his temper with his mother. His parents often fought and ultimately divorced.

Although his relationship with his father improved over the years, his mother became a lonely embittered woman who viewed herself as a victim of unfair life circumstances. She pressured Mr B to take care of her, which he experienced as efforts to draw him away from his wife and job. Although he was angry at his mother's refusal to make efforts to take better care of herself, he felt guilty saying no to her.

Mr B's panic attacks resolved within the first 6 sessions of PFPP, as he began to recognize that his panic arose as a result of intense fears about confronting his employees that were related to his early separation experiences.

In phase 2, his difficulty in tolerating his anger and his fears of abandonment were explored in more depth. It emerged that Mr B felt frightened about reprimanding his employees, because even though he was the boss, he feared that he would be abandoned or punished, just as he felt would happen if he confronted his mother about her selfish behavior. Mr B's panic attacks were also triggered by his rage at his employees, particularly one whose victimized stance reminded him of his mother. Unconsciously, he feared both loss of control of his anger (Mr B's shaking arms during his anxiety and panic) and being abandoned and punished for its expression, which he linked to his being sent away as a child. He had avoided his anger heretofore with reaction formation, taking greater care of his mother while fending off his rage.

In the final phase of treatment, Mr B discussed his frustration and abandonment fears as they emerged in the transference with the therapist. He expressed a concern that the therapist would not be able to tolerate his feelings about leaving the treatment and would become angry with him. Recognizing this transference fear as a fantasy deepened his understanding of the conflicts that had been identified earlier in the treatment. As his fears subsided, Mr B became more effective in his functioning as a boss, and was able to set better limits with his mother. On completion of his 24-session treatment, he had a score of 1 on the PDSS.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

Related content

Is There Empirical Evidence That Supports the Efficacy of Psychodynamic Psychotherapy?

Panic-Focused Psychodynamic Psychotherapy

Psychodynamic Psychotherapy

Psychodynamic Psychopharmacology

Psychodynamic-Oriented Group Therapy: A Pathway to Connection





  • Barlow DH, Gorman JM, Shear MK,Woods SW. Cognitive- behavioral therapy, imipramine, or their combination for panic disorder. JAMA. 2000;283:2529- 2536.
  • Milrod B, Leon AC, Busch F, et al. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry. 2007;164:265- 272.
References
1. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. JAMA. 2000;283:2529-2536.
2. Craske MG, Brown TA, Barlow DH. Behavioral treatment of panic: a two-year follow-up. Behav Ther. 1991;22:289-304.
3. Craske MG, DeCola JP, Sachs AD, Pontillo DC. Panic control treatment for agoraphobia. J Anxiety Disord. 2003;17:321-333.
4. Otto MW, Tuby KS, Gould RA, et al. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry. 2001;158:1989-1992.
5. Bakker A, van Balkom AJ, Spinhoven P. SSRIs vs TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatr Scand. 2002;106:163-167.
6. Wilkinson G, Balestrieri M, Ruggeri M, Bellantuono C. Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorder. Psychol Med. 1991;21:991-998.
7. Marks IM, Swinson RP, Basoglu M, et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. Br J Psychiatry. 1993;162: 776-787.
8. Shear MK, Maser JD. Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry. 1994;51:346-354.
9. Milrod B, Busch F. The long-term outcome of treatments for panic disorder: a review of the literature. J Nerv Ment Dis. 1996;184:723-730.
10. Markowitz JS, Weissman MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry. 1989;46:984-992.
11. Rubin HC, Rapaport MH, Levine B, et al. Quality of well-being in panic disorder: the assessment of psychiatric and general disability. J Affect Disord. 2000;57:217-221.
12. Katon W. Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs. J Clin Psychiatry. 1996;57(suppl 10): 11-18.
13. Swenson RP, Cox BJ, Woszezy CB. Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. J Can Med Assoc. 1992;147:878-883.
14. Fyer AJ, Liebowitz MR, Gorman JM, et al. Discontinuation of alprazolam in panic patients. Am J Psychiatry. 1987;144: 303-308.
15. O'Sullivan G, Marks I. Follow-up studies of behavioral treatment of phobic and obsessive compulsive neurosis. Psychiatr Ann. 1991;21:368-373.
16. American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry. 1998;155(suppl):1-34.
17. Milrod BL, Busch FN, Cooper AM, Shapiro T. Manual of Panic-Focused Psychodynamic Psychotherapy. Washington, DC: American Psychiatric Press; 1997.
18. Milrod B, Leon AC, Busch F, et al. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry. 2007;164: 265-272.
19. Cerny JA, Vermilyea BB, Barlow DH, et al. Anxiety treatment project relaxation treatment manual. 1984. Available from the authors.
20. Breuer J, Freud S. Studies on hysteria. In: Strachey J, ed. The Standard Edition of the Complete Psychological Works of Sigmund Freud. Vol 2. London: Hogarth Press; 1895 (1959):1-183.
21. Busch FN, Cooper AM, Klerman GL, et al. Neurophysiological, cognitive-behavioral and psychoanalytic approaches to panic disorder: toward an integration. Psychoanalytic Inquiry. 1991;11:316-332.
22. Kleiner L, Marshall WL. The role of interpersonal problems in the development of agoraphobia with panic attacks. J Anxiety Disord. 1987;1:313-323.
23. Freud S. The neuropsychoses of defence. In: Strachey J, ed. The Standard Edition of the Complete Psychological Works of Sigmund Freud. Vol 3. London: Hogarth Press; 1894 (1959):45-61.
24. Busch FN, Shear MK, Cooper AM, et al. An empirical study of defense mechanisms in panic disorder. J Nerv Ment Dis. 1995;183:299-303.
25. Freud S. Inhibitions, symptoms and anxiety. In Strachey J, ed. The Standard Edition of the Complete Psychological Works of Sigmund Freud. Vol 20. London: Hogarth Press; 1926 (1959):77-174.
26. Cooper AM. Changes in psychoanalytic ideas: transference interpretation. J Am Psychoanal Assoc. 1987;35:77-98.
27. Shear MK, Cooper AM, Klerman GL, et al. A psychodynamic model of panic disorder. Am J Psychiatry. 1993;150:859-866.
28. Milrod BL, Shear MK. Dynamic treatment of panic disorder: a review. J Nerv Ment Dis. 1991;179:741-743.
29. Kagan J, Reznick JS, Snidman N, et al. Origins of panic disorder. In: Ballenger J, ed. Neurobiology of Panic Disorder. New York: Wiley; 1990:71-87.
30. Milrod B, Leon AC, Shear MK. Can interpersonal loss precipitate panic disorder? Am J Psychiatry. 2004;161:758-759.
31. Busch FN, Milrod BL, Singer MB. Theory and technique in the psychodynamic treatment of panic disorder. J Psychother Prac Res. 1999;8:234-242.
32. Milrod B, Busch F, Leon AC, et al. A pilot open trial of brief psychodynamic psychotherapy for panic disorder. J Psychother Prac Res. 2001;10:1-7.
33. Milrod B, Busch F, Leon A, et al. An open trial of psychodynamic psychotherapy for panic disorder -- a pilot study. Am J Psychiatry. 2000;157:1878-1880.
34. Brown TA, DiNardo P, Barlow DH. Anxiety Disorders Interview Schedule for DSM-IV: Lifetime Version (ADIS-IV-L). New York: Graywinds Publications; 1995.
35. Shear MK, Brown TA, Barlow DH, et al. Multicenter collaborative Panic Disorder Severity Scale. Am J Psychiatry. 1997;154:1571-1575.
36. Sheehan DV. The Sheehan disability scales. In: The Anxiety Disease. New York: Charles Scribner and Sons; 1983:151.
37. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
38. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
39. Otto MW, Pollack MH. Adherence ratings for ART. Available from the authors.
40. Clark DM, Salkovskis PM, Hackman A, et al. A comparison of cognitive therapy, applied relaxation, and imipramine in the treatment of panic disorder. Br J Psychiatry. 1994;164:759-769.
41. Fava GA, Zielezny M, Savron G, Grandi S. Long-term effects of behavioral treatment for panic disorder with agoraphobia. Br J Psychiatry. 1995;166:87-92.
42. Milrod B, Leon AC, Barber JP, et al. Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the APA Practice Guideline. J Clin Psychiatry. 2007;68:885-891.
43. Hoffart A. State and personality in agoraphobic patients. J Pers Disord. 1994;8:333-341.Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. JAMA. 2000;283:2529-2536.Milrod B, Leon AC, Busch F, et al. A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. Am J Psychiatry. 2007;164:265-272.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
RELATED TOPICS

Obsessive-compulsive neurosis
Panic disorder
Panic attacks
Posttraumatic stress disorder (PTSD)
Combat disorders
Traumatic stress disorders

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • The Moral Struggles of Practicing Psychiatrists
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Experts Discuss Changes, Updates in DSM-5
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • You Are—And Your Mood Is—What You Eat
  • Grief and Depression: The Sages Knew the Difference
  • Experts Discuss Changes, Updates in DSM-5
  • Developmental Psychopathology Comes of Age
  • The Psychiatrist and the Slot Machine
  • The Role of Biological Tests in Psychiatric Diagnosis
  • You Are—And Your Mood Is—What You Eat
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • Experts Discuss Changes, Updates in DSM-5
  • The Role of Biological Tests in Psychiatric Diagnosis
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Refinements in ECT Techniques
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
CME
Social Anxiety Disorder: An Update on Evidence-Based Treatment Options
Diagnosis and Treatment of Restless Legs Syndrome in Psychiatric Practice
More Anxiety Disorders CME


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Panic Disorder
Evidence on Panic Disorder
Guidelines on Panic Disorder
Patient Education on Panic Disorder
Clinical Trials on Panic Disorder
Practical Articles on Panic Disorder
Research and Reviews on Panic Disorder
All "Panic Disorder" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy